Cataract Surgery Devices Market Size & Growth Forecast 2027–2036, By Segments (Comorbidity, Age Group, Surgical Technique, End-use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Comorbidity Segment Analysis: Without Comorbidities (Largest & Fastest-Growing Segment)

The without comorbidities segment accounted for the largest market share of 61.98% in 2026 and is also expected to register the fastest growth, reflecting the substantial volume of cataract procedures performed among patients without significant coexisting conditions that could complicate surgical management. This patient group generally allows surgeons to follow established cataract treatment pathways with greater procedural predictability, supporting consistent utilization of standard surgical devices and associated technologies. The segment benefits from the growing prevalence of age-related cataracts, increasing awareness of vision correction options, and greater access to ophthalmic surgical care. Patients without major comorbidities may also be suitable for a broader range of routine cataract interventions, allowing healthcare providers to optimize surgical workflows and achieve efficient patient management. Continued improvements in surgical visualization, lens implantation systems, and precision-oriented instruments are further strengthening device adoption by enabling controlled procedures and reliable outcomes. As ophthalmic centers expand their cataract surgery capabilities and demand for efficient, minimally invasive treatment continues to rise, the without comorbidities segment is expected to maintain its prominent position in the comorbidity segment.

Age Group Segment Analysis: 50 Years & Above (Largest & Fastest-Growing Segment)

The 50 years & above age group accounted for the largest market share of 88.49% in 2026 and is also projected to experience the fastest growth, primarily due to the strong association between advancing age and the development of cataracts. Age-related changes in the eye can progressively reduce lens transparency and visual quality, increasing the need for surgical intervention when vision impairment begins to affect daily activities. The expanding older population is therefore creating a sustained pool of patients requiring cataract diagnosis, treatment, and postoperative care. Greater awareness of age-related vision disorders and improvements in access to ophthalmic services are also encouraging more patients to seek treatment rather than tolerate progressive visual limitations. At the same time, advances in cataract surgery devices are supporting safer, more controlled, and increasingly efficient procedures for older patients. Improved surgical instruments, visualization technologies, and lens delivery systems enable ophthalmologists to address age-related cataracts while supporting streamlined clinical workflows. Demographic aging, increasing demand for vision restoration, and continued advancements in cataract surgery technologies are expected to reinforce the dominance and growth of the 50 years & above age group.

Surgical Technique Segment Analysis: Phacoemulsification (Largest & Fastest-Growing Segment)

The phacoemulsification segment accounted for the largest market share of 63.63% in 2026 and is also expected to register the fastest growth, supported by its widespread adoption as a minimally invasive approach for cataract removal. The technique uses ultrasonic energy to break down the cloudy lens before its removal, allowing surgeons to perform cataract procedures through a relatively small incision and supporting efficient postoperative recovery. Its established clinical use and compatibility with modern cataract surgery workflows have contributed to continued demand for phacoemulsification systems, handpieces, aspiration technologies, and related surgical instruments. Ongoing technological improvements are enhancing precision, fluid management, energy control, and surgeon handling, helping ophthalmologists perform procedures with greater consistency across diverse patient populations. The growing emphasis on efficient surgical workflows is also encouraging healthcare facilities to adopt advanced phacoemulsification platforms that can support reliable performance and streamlined operating-room processes. As cataract prevalence rises with population aging and patients increasingly seek procedures that support faster recovery and improved visual outcomes, continued innovation in phacoemulsification technology is expected to sustain its leading role in the surgical technique segment.